Cited 0 time in
가바펜틴에 의한 스티븐스-존슨 증후군 1예
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 마정은 | - |
| dc.contributor.author | 김현식 | - |
| dc.contributor.author | 박동준 | - |
| dc.contributor.author | 김호철 | - |
| dc.contributor.author | 이종덕 | - |
| dc.contributor.author | 황영실 | - |
| dc.contributor.author | 정이영 | - |
| dc.date.accessioned | 2025-04-08T05:30:14Z | - |
| dc.date.available | 2025-04-08T05:30:14Z | - |
| dc.date.issued | 2007-12 | - |
| dc.identifier.issn | 1226-8739 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/77721 | - |
| dc.description.abstract | 저자들은 gabapentin 복용 3주 후에 전신에 홍반성 반점구진상 발진과 작은 수포 , 구강 점막 탈락 등 SJS으로 내원한 환자에서 항히스타민제와 스테로이드제 투여 후 호전된 예를 경험하였기에 문헌고찰과 함께 보고하는 바이다 . | - |
| dc.format.extent | 7 | - |
| dc.publisher | 대한천식알레르기학회 | - |
| dc.title | 가바펜틴에 의한 스티븐스-존슨 증후군 1예 | - |
| dc.title.alternative | A Case of Stevens-Johnson Syndrome Induced by Gabapentin | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.bibliographicCitation | 천식 및 알레르기, v.27, no.4, pp 283 - 289 | - |
| dc.citation.title | 천식 및 알레르기 | - |
| dc.citation.volume | 27 | - |
| dc.citation.number | 4 | - |
| dc.citation.startPage | 283 | - |
| dc.citation.endPage | 289 | - |
| dc.identifier.kciid | ART001210007 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.subject.keywordAuthor | Stevens-Johnson syndrome | - |
| dc.subject.keywordAuthor | Gabapentin | - |
| dc.subject.keywordAuthor | Stevens-Johnson syndrome | - |
| dc.subject.keywordAuthor | Gabapentin | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
